A Problematic Call for FDA Risk Management

Allan Holmes pointed me to a recent story in the Congress Daily. It seems that Edward Kennedy, D-Mass., who chairs the office of Senate Health, Education, Labor and Pensions Committee Chairman circulated on Monday a list of options for strengthening drug and device safety that are being considered for inclusions in legislation Kennedy's panel is reviewing to improve FDA oversight.

The recent contamination problems with foreign produce heparin that is believed for the deaths of 81 persons in the US as well as chemical-tainted wheat gluten in pet food have been major drivers for strengthening the FDA's oversight capabilities.

The story goes on to say: